Markets have been turning mostly up since the election, as investors have taken the measure of the macro environment and appear pleased. There is some expectation that political matters may settle down, allowing government, public health officials, and the business world to focus on beating the next wave of the coronavirus pandemic.The big news on that front, of course, came from Pharma giants Pfizer and Moderna, which have both announced success in trial phases of COVID vaccines, and are currently on the cusp of gaining emergency use authorization (EUA). The prospect of an early vaccine is bullish for the markets, and has investors looking forward.Oppenheimer’s Chief Investment Strategist John Stoltzfus, looking at the market’s big picture, wrote recently, “In the week ahead investors will have plenty to ponder. We’d expect they are likely to continue to seek out segments of the equity market poised to benefit from a post-Covid environment…”Po